Damora Therapeutics, Inc. Leases Disclosure
8. LEASES
The Company has the following operating leases:
Location |
|
Primary Use |
|
Lease |
|
Renewal Option |
Copenhagen, Denmark |
|
Corporate headquarters |
|
|
None |
The Company has no finance leases and has elected to apply the short-term lease exception to all leases of one year or less. Rent expense for years ended December 31, 2025 and 2024 was $54,000 and $254,000, respectively.
Quantitative information regarding the Company’s leases for the years ended December 31, 2025 and 2024 is as follows (in thousands):
|
|
Year Ended |
|
|||||
Lease Cost: |
|
2025 |
|
|
2024 |
|
||
Operating lease cost |
|
$ |
20 |
|
|
$ |
224 |
|
|
|
|
|
|
|
|
||
Other Information: |
|
|
|
|
|
|
||
Operating cash flows paid for amounts included in the |
|
$ |
20 |
|
|
$ |
223 |
|
Operating lease liabilities arising from obtaining right-of-use |
|
$ |
— |
|
|
$ |
— |
|
As of December 31, 2025 and 2024, the weighted average remaining lease term for operating leases was 3.9 years and 4.9 years, respectively.
As of December 31, 2025 and 2024, the weighted average discount rate for operating leases was 8% for both periods.
Operating lease liabilities are as follows at December 31, 2025 (in thousands):
|
|
Operating |
|
|
2026 |
|
$ |
20 |
|
2027 |
|
|
20 |
|
2028 |
|
|
20 |
|
2029 |
|
|
19 |
|
2030 |
|
|
— |
|
Total lease payments |
|
|
79 |
|
Less: imputed interest |
|
|
(11 |
) |
Total lease liabilities |
|
$ |
68 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 19, 2026 | Showing above |
| 2024 | Mar 19, 2025 | |
| 2023 | Mar 8, 2024 | |
| 2022 | Mar 9, 2023 | |
| 2021 | Feb 17, 2022 | |
| 2020 | Mar 29, 2021 | |
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.